Unilesional plantar mycosis fungoides treated with topical photodynamic therapy - case report and review of the literature.

J Eur Acad Dermatol Venereol

Dermatology Practice Schaffhauserplatz, Zurich, Switzerland.

Published: October 2017

Background: Unilesional mycosis fungoides (UMF) and pagetoid reticulosis (PR) are variants of mycosis fungoides. Conventional therapy comprises surgical excision or radiotherapy, which may be associated with long-term side effects, especially when the lesion is located at a special site like the palms and soles. Therefore, alternative treatment options are needed to treat solitary lesions in the case of UMF or PR. Recently, topical photodynamic therapy (PDT) has been described to be an efficient and non-invasive therapeutical option with excellent clinical outcome.

Objective: The objective of this study was to report a 43-year-old woman with plantar UMF treated successfully with PDT, and to compare our findings with the data on PDT in UMF and PR reported in the literature.

Methods: The literature was analysed for articles on UMF and PR, respectively, treated with topical PDT. Various parameters including form of PDT and response to treatment were analysed and compared with our case.

Results: A total of 24 patients were documented with 24 lesions treated with PDT, either using aminolevulinic acid (ALA) or methylaminolevulinate (MAL). In average, a single lesion was treated 4 times with PDT. In 21 cases (88%), complete response could be achieved, whereas three cases (13%) showed partial remission. None of the cases showed stable or progressive disease.

Conclusions: PDT is a safe, efficient and non-invasive therapeutical approach for the treatment of UMF and PR. It has no long-standing adverse events and therefore is of high therapeutic value especially in cases of UMF and PR located at special sites like the palms and soles. We propose to include topical PDT as therapeutic option for the treatment of UMF and PR in future guidelines on the management MF.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jdv.14160DOI Listing

Publication Analysis

Top Keywords

mycosis fungoides
12
pdt
9
treated topical
8
topical photodynamic
8
photodynamic therapy
8
umf
8
located special
8
palms soles
8
efficient non-invasive
8
non-invasive therapeutical
8

Similar Publications

Article Synopsis
  • Mycosis fungoides (MF) is a rare skin cancer that progresses slowly in early stages but can vary greatly in treatment response and life expectancy once advanced.
  • The BIO-MUSE trial aims to identify specific markers for disease progression using advanced molecular analysis techniques, analyzing tissue and blood samples from a patient over time.
  • Findings highlight potential targets for treatment, such as transforming growth factor β1, suggesting that studying the cancer's evolution alongside the immune response may improve future interventions.
View Article and Find Full Text PDF

Methotrexate (MTX), an antimetabolite targeting certain autoimmune conditions and various hematologic malignancies, has been associated with iatrogenic lymphoproliferative disease (LPD) primarily of B-cell lineage. Less commonly are T-cell neoplasms where primary skin involvement is considered rare. Three cases were encountered in the medical practice of one of the authors.

View Article and Find Full Text PDF

Objective: To highlight the importance of early recognition of hypopigmented mycosis fungoides (HMF) in cases of cutaneous hypochromia in children, with a view to an effective diagnostic and therapeutic approach.

Case Description: Two cases of HMF in children are reported. The first case involves an eight-year-old boy with hypochromic macules on the trunk and root of the upper and lower limbs, while the second case is a six-year-old boy with widespread hypochromic patches.

View Article and Find Full Text PDF

Background And Objectives: Patients with cutaneous lymphomas (CL) are at an increased risk of developing secondary malignancies. This study aimed to assess the frequency of association between CL and Kaposi sarcoma (KS) and to identify factors that may promote the co-occurrence of these two diseases.

Patients And Methods: On January 25, 2024, we conducted a systematic search of four electronic medical databases to identify all published cases of KS associated with CL.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!